4934-35-4

Usage

Uses

Used in Pharmaceutical Industry:
(Methanediyldibenzene-4,1-diyl)dimethanamine is used as a starting material for the synthesis of various pharmaceuticals due to its unique chemical structure and reactivity. It serves as a foundation for creating new drugs with potential therapeutic applications.
Used in Dye Industry:
In the dye industry, (methanediyldibenzene-4,1-diyl)dimethanamine is utilized as a starting material for the production of different types of dyes. Its chemical properties allow for the creation of a variety of colorants used in various applications.
Used in Antibiotic Applications:
(Methanediyldibenzene-4,1-diyl)dimethanamine is being studied for its potential antibiotic properties, showing promise as a compound that could be used in the development of new antibiotics to combat bacterial infections.
Used in Antifungal Applications:
This organic compound is also being investigated for its potential antifungal properties, which could lead to its use in creating new antifungal agents to treat fungal infections.
Used in Material Science:
Due to its unique chemical structure and reactivity, (methanediyldibenzene-4,1-diyl)dimethanamine has been employed in the development of new materials and polymers. Its properties make it a candidate for enhancing the characteristics of various materials in different industries.
Further research is necessary to fully understand the potential applications and properties of (methanediyldibenzene-4,1-diyl)dimethanamine, as its current uses are based on its chemical structure and observed properties, with more extensive studies needed to unlock its full potential.

Upstream product

• 14568-83-3 4,4'-bis(chloromethyl)diphenylmethane 
• 10466-37-2 4,4'-dicyanodiphenylmethane 
• 20248-86-6 4-4'-bis(bromomethyl)biphenyl 
• 16980-01-1 bis(4-bromomethylphenyl)methane 
• 199920-10-0 4,4'-bis(azidomethyl)diphenylmethane 

Downstream Products

• 140661-46-7 C₈₅H₇₄N₁₀O₁₄S₄ 
• 210410-12-1 4'-(tert-butoxycarbonylaminomethyl)-4-aminomethyldiphenylmethane 
• 210410-15-4 [4-(4-{[(6-Hydroxymethyl-pyridin-2-ylmethyl)-amino]-methyl}-benzyl)-benzyl]-carbamic acid tert-butyl ester 
• 210410-17-6 {4-[4-(tert-Butoxycarbonylamino-methyl)-benzyl]-benzyl}-(6-formyl-pyridin-2-ylmethyl)-carbamic acid tert-butyl ester 
• 210410-16-5 {4-[4-(tert-Butoxycarbonylamino-methyl)-benzyl]-benzyl}-(6-hydroxymethyl-pyridin-2-ylmethyl)-carbamic acid tert-butyl ester 
• 210410-13-2 [4-(4-Aminomethyl-benzyl)-benzyl]-(6-{[4-(4-aminomethyl-benzyl)-benzylamino]-methyl}-pyridin-2-ylmethyl)-amine 
• 210410-18-7 {4-[4-({[6-({4-[4-(tert-Butoxycarbonylamino-methyl)-benzyl]-benzylamino}-methyl)-pyridin-2-ylmethyl]-amino}-methyl)-benzyl]-benzyl}-carbamic acid tert-butyl ester 
• 1160285-74-4 N,N'-[methylenebis(4,1-phenylenemethylene)]bis(2-cyanoacetamide) 

Relevant academic research and scientific papers

Synthesis, molecular modeling, and pharmacological testing of bis- quinolinium cyclophanes: Potent, non-peptidic blockers of the apamin- sensitive Ca2+-activated K+ channel

The synthesis and pharmacological testing of two series of novel bis- quinolinium cyclophanes as blockers of the apamin-sensitive Ca2+-activated K+ (SK(Ca)) channel are presented. In these cyclophanes the two 4- aminoquinolinium grou